Post‐hoc analysis on the long‐term response to fixed‐dose prophylaxis with N8‐GP in patients with haemophilia A

Author:

Tiede Andreas1ORCID,Hampton Kingsley2ORCID,Jiménez‐Yuste Victor3ORCID,Young Guy4ORCID,Benchikh el Fegoun Soraya5ORCID,Chowdary Pratima6ORCID

Affiliation:

1. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hanover Germany

2. Department of Cardiovascular Science University of Sheffield Sheffield UK

3. Department of Hematology La Paz University Hospital‐IdiPaz Autónoma University Madrid Spain

4. Hemostasis and Thrombosis Center, Cancer and Blood Disorders Institute, Children's Hospital Los Angeles University of Southern California Keck School of Medicine Los Angeles California USA

5. Global Medical Affairs Biopharm Novo Nordisk Health Care AG Zürich Switzerland

6. Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital London UK

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Reference22 articles.

1. WFH Guidelines for the Management of Hemophilia, 3rd edition

2. Extended half-life recombinant products in haemophilia clinical practice – Expectations, opportunities and challenges

3. Elocta®Summary of product characteristics.https://www.ema.europa.eu/en/documents/product‐information/elocta‐epar‐product‐information_en.pdf

4. Adynovi®Summary of product characteristics.https://www.ema.europa.eu/en/documents/product‐information/adynovi‐epar‐product‐information_en.pdf

5. Jivi®. Summary of product characteristics.https://www.ema.europa.eu/en/documents/product‐information/jivi‐epar‐product‐information_en.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3